2-(((4-Methyl-1H-imidazol-5-yl)methyl)thio)ethanamine

Catalog No. :
ACJIGC605
CAS No. :
38585-67-0
Molecular Formula :
C7H13N3S
Molecular Weight :
171.27

IUPAC Name:2-(((4-methyl-1H-imidazol-5-yl)methyl)thio)ethan-1-amine

2-(((4-Methyl-1H-imidazol-5-yl)methyl)thio)ethanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$107.00Login to see priceInquiryInquiry
1g95%$242.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(((4-Methyl-1H-imidazol-5-yl)methyl)thio)ethanamine
IUPAC Name2-(((4-methyl-1H-imidazol-5-yl)methyl)thio)ethan-1-amine
MDL No.MFCD05668149
Molecular FormulaC7H13N3S
Molecular Weight171.27
SMILESCC1=C(CSCCN)NC=N1
InChI KeyJEOZNMMOIBLWLV-UHFFFAOYSA-N
Synonym4-[[(2-aminoethyl)thio]methyl]-5-methylimidazole;2-(((5-Methyl-1H-imidazol-4-yl)methyl)thio)ethanamine;4-[(2-Aminoethyl)thiomethyl]-5-methyl-1H-imidazole;(2-{[(4-methyl-1H-imidazol-5-yl)methyl]thio}ethyl)amine;Ethanamine, 2-[[(4-methyl-1H-imidazol-5-yl)methyl]thio]-;2-{[(4-Methyl-1H-imidazol-5-yl)methyl]sulfanyl}ethanamine;2-(((4-Methyl-1H-imidazol-5-yl)methyl)thio)ethan-1-amine
CAS No.38585-67-0

Synthetic Route by SureRoute

1. ACJIGC605 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBHDL826 route compound structure diagram
    ACBHDL82638585-62-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJIGC605 route product structure diagram
    ACJIGC60538585-67-0
Inquiry

2. ACJIGC605 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWEOL817 route compound structure diagram
    ACWEOL817928113-28-4 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACJIGC605 route product structure diagram
    ACJIGC60538585-67-0
Inquiry

Comments (0)